Weak self-association of human growth hormone investigated by nitrogen-15 NMR relaxation

Proteins: Structure, Function and Genetics

Volumn 73, Issue 1, 2008, Pages 161-172

  Jensen, Malene Ringkjøbing ^a,d   Kristensen, Søren M ^a   Keeler, Camille ^b   Christensen, Hans E M ^c   Hodsdon, Michael E ^b   Led, Jens J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d INSTITUT DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Hydrodynamic calculations; Model free analysis; Rotational diffusion of proteins; Transient protein protein interactions

Indexed keywords

HUMAN GROWTH HORMONE; MONOMER;

ANISOTROPY; ARTICLE; CONCENTRATION RESPONSE; HYDRODYNAMICS; NITROGEN NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

HUMAN GROWTH HORMONE; HUMANS; NITROGEN ISOTOPES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RECOMBINANT PROTEINS;

EID: 50849112804     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22039     Document Type: Article

References (71)

1. Adams MJ, Blundell TL, Dodson EJ, Dodson GG, Vijayan M, Baker EN, Harding MM, Hodgkin DC, Rimmer B, Sheat S. Structure of Rhombohedral 2 Zinc Insulin Crystals. Nature 1969;224:491-495.
2. Blundell TL, Cutfield JF, Cutfield SM, Dodson EJ, Dodson GG, Hodgkin DC, Mercola DA, Vijayan M. Atomic positions in rhombohedral 2-zinc insulin crystals. Nature 1971;231:506-511.
3. Blundell TL, Dodson GG, Hodgkin DC, Mercola DA. Insulin: the structure in the crystal and its reflection in chemistry and biology. Adv Prot Chem 1972;26:279-402.
4. Derewenda U, Derewenda Z, Dodson EJ, Dodson GG, Reynolds CD, Smith GD, Sparks C, Swenson D. Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer. Nature 1989;338:594-596.
5. Chang X, Jørgensen AMM, Bardrum P, Led JJ. Solution structures of the R6 human insulin hexamer. Biochemistry 1997;36:9409-9422.
6. Cunningham BC, Bass S, Fuh G, Wells JA. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 1990;250:1709-1712.
7. Cunningham BC, Mulkerrin MG, Wells JA. Dimerization of human growth hormone by zinc. Science 1991;253:545-548.
8. Dienys G, Sereikaitè J, Lukša V, Jarutienè O, Mištinienè E, Bumelis VA. Dimerization of human growth hormone in the presence of metal ions. Bioconjugate Chem 2000;11:646-651.
9. Dobson CM. Getting out of shape. Nature 2002;418:729-730.
10. Dobson CM. Protein folding and misfolding. Nature 2003;426:884-890.
11. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003;26:267-198.
12. Tycko R. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys 1998;31:1-39.
13. Tycko R. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol 2004;14:96-103.
14. Lester-Coll, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. Intracerebral strepto-zotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 2006;9:13-33.
15. Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E. Toward understanding insulin fibrillation. J Pharm Sci 1997;86:517-525.
16. Nettleton EJ, Tito P, Sunde M, Bouchard M, Dobson CM, Robinson CV. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. J Biophys 2000;79:1053-1065.
17. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of molecular mechanism. Biochemistry 2001;40:6036-6046.
18. Eckhardt BM, Oeswein JQ, Bewley TA. Effect of freezing on aggregation of human growth hormone. Pharm Res 1991;8:1360-1364.
19. Pikal MJ, Dellerman KM, Roy ML, Riggin RM. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm Res 1991;8:427-436.
20. Katakam M, Bell LM, Banga AK. Effect of surfactants on the physical stability of recombinant human growth hormone. J Pharm Sci 1995;84:713-716.
21. Maa YF, Hsu C. Aggregation of recombinant human growth hormone induced by phenolic compounds. Int J Pharm 1996;140:155-168.
22. Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 1974;22:1141-1158.
23. Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 1998;95:4224-4228.
24. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999;96:3590-3594.
25. Fandrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001;410:165-166.
26. Khurana R, Ionescu-Zanetti C, Pope M, Li J, Nielson L, Ramirez-Alvarado M, Regan L, Fink AL, Carter SA. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys J 2003;85:1135-1144.
27. Dobson CM. The structural basis of protein folding and its links with human disease. Phil Trans R Soc Lond B 2001;356:133-145.
28. Lee S, Fernandez EJ, Good TA. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the β fibril formation pathway. Prot Sci 2007;16:723-732.
29. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002;416:507-511.
30. Chawla RK, Parks JS, Rudman D. Structural variants of human growth hormone: biochemical, genetic, and clinical aspects. Annu Rev Med 1983;34:519-547.
31. Isaksson OGP, Edén S, Jansson JO. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 1985;47:483-499.
32. Wells JA, de Vos AM. Structure and function of human growth hormone implications for the hematopoietins. Annu Rev Biophys Biomol Struct 1993;22:329-351.
33. Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 2001;12:252-257.
34. Lewis UJ, Peterson SM, Bonewald LF, Seavey BK, Vanderlaan WP. An interchain disulfide dimer of human growth hormone. J Biol Chem 1977;252:3697-3702.
35. Moore WV, Leppert P. Role of aggregated human growth hormone (hGH) in development of antibodies to hGH. J Clin Endocrinol Metab 1980;51:691-697.
36. Becker GW, Bowsher RR, Mackellar WC, Poor ML, Tackitt PM, Riggin RM. Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormone. Biotechnol Appl Biochem 1987;9:478-487.
37. DeFilippis MR, Alter LA, Pekar AH, Havel HA, Brems DN. Evidence for self-associating equilibrium intermediate during folding of human growth hormone. Biochemistry 1993;32:1555-1562.
38. Gomez-Orellana I, Variano B, Miura-Fraboni J, Milstein S, Paton DR. Thermodynamic characterization of an intermediate state of human growth hormone. Prot Sci 1998;7:1352-1358.
39. St John RJ, Carpenter JF, Balny C, Randolph TW. High pressure refolding of recombinant human growth hormone from insoluble aggregates. J Biol Chem 2001;276:46856-46863.
40. Cleland JL, Powell MF, Shire SJ. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst 1993;10:307-377.
41. Carpenter JF, Kendrick BS, Chang BS, Manning MC, Randolph TW. Inhibition of stress-induced aggregation of protein therapeutics. Methods Enzymol 1999;309:236-255.
42. Ratner RE, Phillips TM, Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 1990;39:728-733.
43. Nagatomi Y, Ikeda M, Uchida H, Wada M, Kobayashi H, Hashimoto Y, Mabuchi K, Hayakawa M, Kusuhara N, Honjo M. Reversible dimerization of 20 kilodalton human growth hormone (hGH). Growth Hormone IGF Res 2000;10:207-214.
44. Hansen DF, Hass MAS, Christensen HM, Ulstrup J, Led JJ. Detection of short-lived transient protein-protein interactions by intermolecular nuclear paramagnetic relaxation: plastocyanin from Anabaena variabilis. J Am Chem Soc 2003;125:6858-6859.
45. Iwahara J, Clore GM. Detecting transient intermediates in macromolecular binding by paramagnetic NMR. Nature 2006;440:1227-1230.
46. Tang C, Iwahara J, Clore GM. Visualization of transient encounter complexes in protein-protein association. Nature 2006;444:383-386.
47. Volkov AN, Worrall JAR, Holtzmann E, Ubbink M. Solution structure and dynamics of the complex between cytochrome c and cytochrome c peroxidase determined by paramagnetic NMR. Proc Natl Acad Sci USA 2006;103:18945-18950.
48. Aakerud T, Thulin E, van Etten RL, Akke M. Intramolecular dynamics of low molecular weight protein tyrosine phosphatase in monomer-dimer equilibrium studied by NMR: a model for changes in dynamics upon target binding. J Mol Biol 2002;322:137-152.
49. Bernado P, Aakerud T, de la Torre JG, Akke M, Pons M. Combined use of NMR relaxation measurements and hydrodynamic calculations to study protein association. Evidence for tetramers of low molecular weight protein tyrosine phosphatase in solution. J Am Chem Soc 2003;125:916-923.
50. 2+, and pH. Endocrinology 2002;143:1302-1309.
51. Kasimova MR, Kristensen SM, Howe PWA, Christensen T, Matthiesen F, Petersen J, Sørensen HH, Led JJ. NMR studies of the backbone flexibility and structure of human growth hormone: a comparison of high and low pH Conformations. J Mol Biol 2002;318:679-695.
52. Lipari G, Szabo A. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. I. Theory and range of validity. J Am Chem Soc 1982;104:4546-4559.
53. Lipari G, Szabo A. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. II. Analysis of experimental results. J Am Chem Soc 1982;104:4559-4570.
54. Clore GM, Szabo A, Bax A, Kay LE, Driscoll PC, Gronenborn AM. Deviations from the simple 2-parameter model-free approach to the interpretation of N-15 nuclear magnetic-relaxation of proteins. J Am Chem Soc 1990;112:4989-4991.
55. Mandel AM, Akke M, Palmer AG. Backbone dynamics of Escherichia coli ribonuclease HI: correlation with structure and function in an active enzyme. J Mol Biol 1995;246:144-163.
56. Kristensen SM. Fuda: a function and data fitting and analysis package. Department of Chemistry, University of Copenhagen, 2005.
57. de la Torre JG, Huertas M, Carrasco B. HYDRONMR: prediction of NMR relaxation of globular proteins from atomic-level structures and hydrodynamic calculations. J Magn Reson 2000;147:138-146.
58. 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry 1989;28:8972-8979.
59. Keeler C, Dannies PS, Hodsdon ME. The tertiary structure and backbone dynamics of human prolactin. J Mol Biol 2003;328:1105-1121.
60. de la Torre JG, Navarro S, Martinez MCL, Diaz FG, Cascales JJL. HYDRO: a computer-program for the prediction of hydrodynamic properties of macromolecules. Biophys J 1994;67:530-531.
61. Tjandra N, Bax A. Direct measurement of distances and angles in biomolecules by NMR in a dilute liquid crystalline medium. Science 1997;278:1111-1114.
62. Schurr JM, Babcock HP, Fujimoto BS. A test of the model-free formulas. Effects of anisotropic rotational diffusion and dimerization. J Magn Reson Series B 1994;105:211-224.
63. Fushman D, Cahill S, Cowburn D. The main-chain dynamics of the dynamin pleckstrin homology (PH) domain in solution: analysis of 15N relaxation with monomer/dimer equilibration. J Mol Biol 1997;266:173-194.
64. Yang S, Levine H, Onuchic JN. Protein oligomerization through domain swapping: role of inter-molecular interactions and protein concentration. J Mol Biol 2005;352:202-211.
65. Song G, Jernigan RL. An enhanced elastic network model to represent the motions of domain-swapped proteins. Prot Struct Funct Bioinform 2006;63:197-209.
66. Bennett MJ, Sawaya MR, Eisenberg D. Deposition diseases and 3D domain swapping. Structure 2006;14:811-824.
67. Ding F, Prutzman KC, Campbell SL, Dokholyan NV. Topological determinants of protein domain swapping. Structure 2006;14:5-14.
68. Chan Y, Cheng C, Chan K. Study of goldfish (Carassius auratus) growth hormone structure-function relationship by domain swapping. Comparat Biochem Physiol B 2007;146:384-394.
69. Zorrilla S, Hink MA, Visser AJ, Lillo MP. Translational and rotational motions of proteins in a protein crowded environment. Biophys Chem 2007;125:298-305.
70. Jones S, Thornton JM. Principles of protein-protein interactions. Proc Natl Acad Sci USA 1996;93:13-20.
71. Hwang TL, van Zijl PCM, Mori S. Accurate quantification of wateramide proton exchange rates using the phase-modulated CLEAN chemical exchange (CLEANEX-PM) approach with a fast-HSQC (FHSQC) detection scheme. J Biomol NMR 1998;11:221-226.